US 10,329,269 B2Granted

Indene derivatives and uses thereof

AssigneesLeukogene Therapeutics Incorporated, MUSC Foundation for Research Development

InventorsNathan G. Dolloff, Reeder M. Robinson, Allen B. Reitz, Haiyan Bian

Life of this patent

Estimating the term…

Abstract

The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.

Claims2

Dependent claims

A compound, wherein said compound is:

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 16/115,780Filed 29 Aug 2018 · us provisional application
Priority: 31 Aug 2017
Published: US 2019/0062298 A128 Feb 2019
Granted: 25 Jun 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification26 codes

C07D 317/70
Ortho- or peri-condensed with carbocyclic rings or ring systems: condensed with ring systems containing two or more relevant rings
A61P 35/00
Antineoplastic agents
C07C 39/38
Halogenated derivatives: with at least one hydroxy group on a condensed ring system containing two rings
C07C 39/42
Halogenated derivatives: containing six-membered aromatic rings and other rings

Family

Application62/552,449Us provisional application · filed 31 Aug 2017
US 2019/0062298 A1Pre-grant publication · published 28 Feb 2019
US 10,329,269 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…